Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary
Authors
Nektaria Alexandri (ORCID: https://orcid.org/0000-0002-9806-8358)
Dawn Langdon (ORCID: https://orcid.org/0000-0003-1128-7417)
Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary
Nektaria Alexandri, Dawn Langdon, Jeannette Lechner‐Scott, Xavier Montalbán et al.
Local Database Links
1 links
Journal
Neurodegenerative Disease Management
Topics
Multiple Sclerosis Research Studies
article
Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary
Nektaria Alexandri, Dawn Langdon, Jeannette Lechner‐Scott, Xavier Montalbán, Krzysztof Selmaj, Andrzej Smyk, Axel Nolting, Alessandra Solari, Francesco Patti, Luís Brieva, Bruno Brochet, Eva Havrdová, Fredrik Piehl, Raymond Hupperts, Eva Maria Maidal
article en
Abstract
No abstract available for this paper.
Publication Tag
Neurodegenerative Disease ManagementVol. 14(6)
Institutions
Université de Bordeaux (FR), Inserm (FR), Merck KGaA, Darmstadt (Germany) (DE), Royal Holloway University of London (GB), Charles University (CZ), John Hunter Hospital (AU), Karolinska Institutet (SE), Maastricht University (NL), University of Catania (IT), Hospital Arnau de Vilanova (ES), Neurocentre Magendie (FR), Vall d'Hebron Hospital Universitari (ES), Zuyderland Medisch Centrum (NL), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), University of Warmia and Mazury in Olsztyn (PL), University of Newcastle Australia (AU)